Psychotropic medications selectively reshape the human gut microbiota and alter neuroactive metabolite production

Abstract Psychotropic medications are widely prescribed and increasingly recognised to alter the gut microbiome. However, the mechanisms underlying these drug-microbiome interactions and their consequences for neuroactive microbial metabolism remain poorly understood. Here, we investigated the impact of commonly prescribed antidepressants and antipsychotics on gut microbiomes ex vivo. Among the drugs tested, sertraline and aripiprazole had the strongest effects on the gut microbiome, reducing overall microbial loads and altering the abundance of approximately 21% and 11% of microbial functional pathways, respectively. Both drugs also substantially remodelled microbial metabolism, affecting the production of microbial metabolites implicated in gut-brain signalling. Sertraline and aripiprazole both reduced indole levels, but the drugs had opposing effects on short-chain fatty acid production, which decreased with sertraline and increased with aripiprazole. Transcriptomic analyses of sertraline-exposed microbial cells revealed widespread disruption of membrane-associated transport and energy metabolism, with microscopy further supporting membrane dysfunction. By contrast, tametraline, a non-chlorinated and less lipophilic structural analogue of sertraline, produced negligible transcriptomic and microbiome-level effects. Together, our findings identify sertraline’s dichlorophenyl moiety and high lipophilicity as key determinants of microbial membrane dysfunction, establishing a mechanistic link between drug chemical structure, microbiome toxicity, and metabolic remodelling.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11525173/v1
Primary Topic
Gut microbiota and health
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Psychotropic medications selectively reshape the human gut microbiota and alter neuroactive metabolite production

Jessica L. Teeling, Jonathan Richard Swann, Fátima C. Pereira, Juwairiyah B. Shazzad et al.
2 links
Research Square
Gut microbiota and health
preprint

Psychotropic medications selectively reshape the human gut microbiota and alter neuroactive metabolite production

Jessica L. Teeling, Jonathan Richard Swann, Fátima C. Pereira, Juwairiyah B. Shazzad, William Lane, Paul Afolabi
preprint en

Abstract

Abstract Psychotropic medications are widely prescribed and increasingly recognised to alter the gut microbiome. However, the mechanisms underlying these drug-microbiome interactions and their consequences for neuroactive microbial metabolism remain poorly understood. Here, we investigated the impact of commonly prescribed antidepressants and antipsychotics on gut microbiomes ex vivo. Among the drugs tested, sertraline and aripiprazole had the strongest effects on the gut microbiome, reducing overall microbial loads and altering the abundance of approximately 21% and 11% of microbial functional pathways, respectively. Both drugs also substantially remodelled microbial metabolism, affecting the production of microbial metabolites implicated in gut-brain signalling. Sertraline and aripiprazole both reduced indole levels, but the drugs had opposing effects on short-chain fatty acid production, which decreased with sertraline and increased with aripiprazole. Transcriptomic analyses of sertraline-exposed microbial cells revealed widespread disruption of membrane-associated transport and energy metabolism, with microscopy further supporting membrane dysfunction. By contrast, tametraline, a non-chlorinated and less lipophilic structural analogue of sertraline, produced negligible transcriptomic and microbiome-level effects. Together, our findings identify sertraline’s dichlorophenyl moiety and high lipophilicity as key determinants of microbial membrane dysfunction, establishing a mechanistic link between drug chemical structure, microbiome toxicity, and metabolic remodelling.

Research Square
University of Southampton (GB)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon